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Chronic obstructive lung disease is the main reason for the development of chronic cor pulmonale. 
Comorbidity of this disease with cardiovascular pathology is the most important, reflecting the unity of 
cardiorespiratory system, becoming a summary integral factor of a negative prognosis: chronic obstructive 
lung disease and cardiovascular diseases are considered as “criminal partners”. 
The aim of the study was to investigate the functional state of left ventricular myocardium in patients 
with chronic cor pulmonale of broncho-pulmonary genesis combined with hypertensive disease.  
Objects of the study were 96 patients with chronic cor pulmonale in combination with hypertensive 
disease depending on the disease severity. Among them 32 patients were without signs of circulatory 
insufficiency – compensation stage, and 64 were with signs of circulatory insufficiency of II stage -  
decompensation stage – forming the main group. The comparative group included 64 patients with chronic 
cor pulmonale without hypertensive disease, among whom 32 patients without signs of circulatory 
insufficiency and 32 patients with signs of circulatory insufficiency of II stage. The control group was 
consisted of 15 practically healthy individuals. All groups were of the same sex and age. 
It was established the systolic dysfunction of the left ventricle worsens in case of adding of 
hypertensive disease to chronic cor pulmonale. Revealed significant decrease of the stroke and cardiac 
indices, acceleration of blood flow through aortic valve, that resulted in decrease of ejection fraction, testifies 
about it.  These differences were the most evident in patients of decompensation stage, when also increased 
hypertrophy of the left ventricular posterior wall and, particularly, interventricular septum was revealed.  
Diastolic dysfunction appears already on the background of chronic cor pulmonale formation in 
patients with chronic obstructive pulmonary disease and intensifies significantly in case of adding of 
hypertensive disease, in development of circulatory insufficiency particularly. It was confirmed by revealed 
changes of the left ventricular diastolic function of relaxation type among all the patients. They were 
reflected in diminishing of early diastolic filling velocity, ratio of early to late filling velocity, increase of 
isovolumic relaxation time, particularly in presence of hypertensive disease and signs of circulatory 
insufficiency. Significant thickening of interventricular septum also testifies about forming of left ventricular 
diastolic dysfunction. 
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Introduction 
 Diseases of respiratory organs have a great percentage, and morbidity remains high despite the 
developed therapeutic complexes [Gavrysiuk V, Feshchenko Yu, 2011]. Chronic cor pulmonale is a 
widespread pathology in the practice of therapeutist, geriatrician, cardiologist. According to the definition of 
Ukrainian Association of Phthisiatricians and Pulmonologists [Gavrysiuk V, Merenkova Ye, 2014], chronic 
cor pulmonale is a syndrome of circulatory insufficiency with development of peripheral edemas that 
complicates the course of many diseases with lesion of lungs’ structure or function itself. In the most 
frequent cases chronic cor pulmonale is a result of forming and steady progressing of chronic obstructive 
lung disease, particularly among elderly and old people.  The rate of increase of chronic obstructive lung 
disease is worthy of a peculiar note. So, in 1990 chronic obstructive lung disease took the 12th place in the 
structure of morbidity, according to experts of WHO prognosis it will have entered into the first five 
pathologies (after ischemic heart disease, depression, traumas which are results of accidents and diseases  of 
cerebral vessels) by 2020. Moreover, chronic obstructive lung disease took the 4th place among ten leading 
causes of death in 2008, but this disease will be shifted to the 3rd place by 2020. It can cause 6 million deaths 
[GOLD, 2011; Gibson G et al., 2013]. Every year 5-7 new cases are diagnosed among 30-45 cases of 
obstructive disease [Shmelev Ye, 2003]. Thereby, morbidity in absolute figures makes approximately 100 
million per year. Annually 3 million people die from chronic obstructive lung disease [Feshchenko Yu, 
2012]. Unfavorable prognoses concerning the increase in frequency of chronic obstructive lung disease are 
based both on the researches in Europe and in the regions of the American continent [Vestbo J et al.,2013; 
Yakovleva O, Masloyed T, 2014], different variants of phenotypes are taken into account. Problem becomes 
complicated in condition of comorbidity of chronic obstructive lung disease [Nesen A et al., 2015]. The 
amount of patients with chronic cor pulmonale as a result of complicated chronic obstructive lung disease 
has increased. Lethality among them takes the 3rd place after arterial hypertension and ischemic heart 
disease, particularly among causes of death of individuals over 50 years [Konoplyova L, Rudenko Yu, 2009].  
Today chronic obstructive lung disease is considered as a multidisciplinary problem [Avdeyev S, 
Baymakanova G, 2008; Cavailles A et al., 2013] owing to its frequent combination with obesity, metabolic 
disorders, cachexia, dementia. But it is comorbidity of this disease with cardiovascular pathology which is 
the most important; it reflects the unity of cardiorespiratory system, becoming a summary integral factor of a 
negative prognosis: chronic obstructive lung disease and cardiovascular diseases are considered as “criminal 
partners”. Comorbidity often remains the first among the risk factors of frequent exacerbations of chronic 
obstructive lung disease, and every exacerbation approximates the irreversible outcome. So, combination of 
bronchitis with ischemic heart disease increases death risk by 50%, moreover, the decrease of forced 
expiratory volume per 1 second by every 10% causes the growth of death risk by 14 % or cardiac death by 
28% [Cavailles A et al., 2013]. 
The major epidemiological research Lung Health Study established that cardiovascular diseases are 
the main reasons for the hospitalization of patients with obstructive disease in 42% cases, whereas 
respiratory complications are only in 14%. 
According to the data of N.A.Karoli and A.P. Rebrov (2005), the pathology of cardiovascular system 
is revealed in 61,8% patients with chronic obstructive pulmonary disease, besides frequency of arterial 
hypertension varies in a wide diapason – from 6.8 to 76.3%, on average making 34.3%. Other authors inform 
that prevalence of combination of chronic obstructive lung disease and arterial hypertension makes 28% 
[Mannino D et al., 2008; Yachnik A, 2009]. It is considered that chronic hypoxia, caused by chronic 
obstructive lung disease, promotes to elevation of blood pressure by means of worsening of endothelium-
dependent vasodilating mechanisms [Chuchalin A, 2010]. In case of variation in intrathoracic pressure which 
appears during episodes of bronchial obstruction, sympathetic nervous system activates and vasoconstriction 
develops. It is accompanied by elevation of blood pressure. 
The formation of chronic cor pulmonale in patients with chronic obstructive lung disease is an 
unfavorable factor for prognosis [Rakhimova D, 2012]; myocardial lesion develops as result of hypoxia, 
intoxication, pulmonary hypertension’s development, that causes disorder of its contractile ability [Adamyan 
K, 2013]. Even insignificantly expressed pulmonary hypertension is additional pathogenic factor of 
myocardial pump function’s disorders rise. Adding of hypertensive disease provokes progressing of 
disorders in pulmonary circulation, promotes to worsening of bronchial patency and development of chronic 
heart failure. 
Thus, significant prevalence, frequent exacerbations and involvement into pathological process of 
adjacent organs determine the actuality of studying the problem of the development of chronic cor pulmonale 
of broncho-pulmonary genesis. Combination of chronic cor pulmonale in patients with chronic obstructive 
lung disease and hypertensive disease causes peculiar clinical interest.  
The aim of the study was to investigate the functional state of the left ventricular myocardium in 
patients with chronic cor pulmonale of broncho-pulmonary genesis combined with hypertensive disease.  
Material and methods 
For the solution of this question systolic and diastolic functions of the left ventricular myocardium 
were studied in 96 patients with chronic cor pulmonale combined with hypertensive disease depending on 
the disease severity, among them 32 patients (33.3%) without signs of circulatory insufficiency – 
compensation stage (I group), 64 (66.7%) – with signs of circulatory insufficiency of II stage – 
decompensation stage (II group). The number of males was 58 (60.4%) and females - 58 (60.4%), the mean 
age was 55.6±2.2 years. These patients formed the main group. Obtained results were compared with 
identical group of patients with chronic cor pulmonale without hypertensive disease, among whom 32 
(50.0%) patients without signs of circulatory insufficiency – compensation stage (III group), 32 (50.0%) 
patients with signs of circulatory insufficiency of II stage – decompensation stage (IV group). There were 40 
males (62.0%) and 24 females (38.0%) with the mean age of 53.5±1.2 years. These patients formed the 
comparative group. The control group was consisted of 15 practically healthy individuals. All groups were of 
the same sex and age.  
Diagnosis of chronic cor pulmonale was established based on clinical and instrumental signs of right 
ventricular hypertrophy and/or dilatation of right ventricular cavity and right atrium [Roytberg G, Strutynsky 
A, 2003; Gavrysiuk V, 2007].  
Estimation of morphological changes and functional condition of left parts of the heart was carried 
out by means of two-dimensional echocardiography by apparatus Toschiba SSA, 380A Powerwission 
(Japan) with determination of common indices characterizing systolic and diastolic function of left ventricle. 
The following indices of diastolic function of left ventricle were estimated: early diastolic filling velocity (E) 
and late diastolic filling velocity (A), ratio E/A, isovolumic relaxation time by indices of transmitral blood 
flow.  
Diameter of the left atrium, cardiac index, stroke index, thickness of left ventricular posterior wall, 
ejection fraction were determined with the aim of estimation of systolic function of the left ventricle.  
The classification of the work group of Ukrainian Association of Phthisiatricians, Pulmonologists 
and Cardiologists was used for the estimation of circulatory insufficiency in patients with chronic cor 
pulmonale [Gavrysiuk V, Yachnik A, 2005]. 
Parameters of systolic and diastolic blood pressure were measured by Korotkov’s method; the value 
of arterial hypertension was estimated according to the classification of hypertensive disease accepted in 
Ukraine in 1992(the order of Ministry of Health of Ukraine, N206 from 30.12.92). Informed consent for 
participation in the research signed by the patient was the obligatory condition in order to let the patient take 
part in the research. 
Statistical analysis of the results was carried out by parametric statistics. Student’s t-test was used to 
estimate the significance of differences. The difference of indices was significant in case of p<0,05, and also 
by means of nonparametric Kolmogorov-Smirnov test.  
Results and discussion 
The indices of left ventricular myocardium obtained during echocardiographic study in patients with 




Indices of systolic and diastolic function of the left ventricle  
in examined patients and healthy individuals 
 
Indices 
Control group  
n=15 
 Main group  Comparative group 
I II III IV 
n = 32 n = 64 n = 32 n = 32 
Systolic blood pressure 
(mm Hg) 
130.0±1.5 145.0±1,5* 160.0±2.5* 120.0±2.0 120.0±2.0 
Diastolic blood pressure 
(mm Hg) 
80.0±1,0 90.0±1.2 95.0±1.3 85.0±2.0 80.0±2.0 
Heart rate per 1 minute 72.1±1.9 88.0±1.5* 95.0±3.0* 78.0±2.0 80.0±2.0 
Stroke index (ml/m2) 43.7±1.9 36.5±1.2* 30.0±1.4* 42.0±1.3 40.0±1.2 
Сardiac index 3.1±0.1 2.4±0.4 2.1±0.6 3.0±0.3 2.8±0.2 
(l/min/m2) 
Ejection fraction ( %) 65.7±0.6 50.0±2.5* 40.5±1.0* 63.4±1.2 58.5±2.0 
Thickness of left 
ventricular posterior 
wall (mm) 
9.1±0.2 9.6±0.4 9.8±0.3* 8.2±0.4 8.7±0.3 
Interventricular septum 
(mm) 
8.9±0.2 10.4±0.6 11.5±0.5* 8.0±0,3 9.2±0.3 
Vmaх (m/sec) 1.2±0.03 0.8±0.002 0.5±0.003* 1.0±0.02 0.9±0.003 
Acceleration of blood 
flow through aortic 
valve, (m/sec2) 
18.7±0.9 9.2±0.3* 7.5±0.2* 16.8±0.4 14.2±0.2 
Diameter of  the left 
atrium (mm) 
28.1±0.7 34.0±0.8 37.0±1.2* 29.0±1.0 32.0±0.9 
Е (m/sec) 0.84±0.04 0.6±0.002 0.4±0.001* 0.8±0.003 0.7±0.002 
А (m/sec) 0.5±0.04 0.4±0.001 0.3±0.002* 0.5±0.002 0.5±0.003 
Е/А (c.u.) 1.74±0.06 1.5±0.02 1.3±0.03 1.6±0.02 1.4±0.01 
Isovolumic relaxation 
time (sec) 
0.07±0.001 0.13±0.002* 0.16±0.004* 0.09±0.001 0.11±0.002 
Note: *- significance of differences of indices among patients of I, III groups in compensation stage 
and II, IV groups in decompensation stage; р <0.05. 
 
The table demonstrates that significant decrease of the stroke and cardiac indices, acceleration of 
blood flow through aortic valve were revealed in patients with chronic cor pulmonale combined with 
hypertensive disease even during compensation stage (Р<0.05). It resulted in decrease of ejection fraction in 
1.5 times in comparison with healthy individuals, but this index was within limits of normal value 
(50.0±2.5%). These changes indicate additional contribution of hypertensive disease to development of 
systolic function’s decrease on the background of hypoxia, toxic-infectious and metabolic influences of 
chronic obstructive lung disease. These differences are more evident in patients of II group, that was 








All indices (stroke and cardiac indices, Vmaх, acceleration of blood flow through aortic valve, 
diameter of the left atrium) were changed significantly. It resulted in decrease of ejection fraction to 
40.5±1.0%. Increasing hypertrophy of the left ventricular posterior wall and interventricular septum, 
particularly, were revealed. But they didn’t reach values, which are typical of isolated hypertensive disease. 
Pathogenesis of these changes can be explained by diminishing of blood flow to the left part of the heart due 
to increase of total pulmonary resistance, pulmonary hypertension in pulmonary circulation and right 
ventricular failure.  
Changes of the left ventricular diastolic function by a relaxation type were revealed in 100% 
patients. They were reflected in diminishing of early diastolic filling velocity (E), ratio of early to late filling 
velocity (E/A), particularly among the patients of II group. The difference of indices was, correspondingly, 
0.3±0,001 m/sec (p <0.05) and 0.1±0.001 c.u. in comparison with IV group of patients. Index of isovolumic 
relaxation time increased from 0.11±0.002 sec in patients of IV group to 0.16±0.04 sec in patients of II group 
(р <0.05). Significant thickening of interventricular septum also testifies about forming of the left ventricular 
diastolic dysfunction. It is necessary to mention that disorder of left ventricle’s filling together with changes 
of systolic function was accompanied by its dilatation by 7.6%. 
The obtained results testify that not only the right ventricular myocardium’s lesion (see our 
preceding works [Каzakov Yu et al., 2016]) but also left ventricular myocardium’s lesion play significant 
role in development of chronic cor pulmonale. The simultaneous course of chronic obstructive lung disease 
and hypertensive disease is accompanied by syndrome of “mutual burden”. 
Thus, the analysis of obtained results demonstrates that systolic dysfunction of left ventricle (like one 
of right ventricle) increases in case of adding of hypertensive disease to cor pulmonale. Not only elevated 
blood pressure, decreased contractile ability of myocardium, but also hypoxia, myocardial dystrophy, which 
are typical of the patients with chronic obstructive lung disease, that is confirmed by data of other scientists 
[Amosova K et al, 2008], have influence on the changes of cardiac ventricles. 
Diastolic dysfunction occurs on the background of forming of chronic cor pulmonale in patients with 
chronic obstructive lung disease and significantly intensifies in case of adding of hypertensive disease, 
particularly in development of circulatory insufficiency.  
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